ASTRIA THERAPEUTICS, INC.
ASTRIA THERAPEUTICS, INC. logo

Astria Therapeutics is a biopharmaceutical company, and it's mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Astria's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema.

Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.

© 2023-24 DxMultiomics. All rights reserved.